作者
Rebecca SY Wong
发表日期
2021
来源
International journal of clinical and experimental pathology
卷号
14
期号
7
页码范围
831
出版商
e-Century Publishing Corporation
简介
The coronavirus disease 2019 (COVID-19) was declared a pandemic in March 2020 by the World Health Organization (WHO). To date, there were> 163 million confirmed cases of COVID-19 and the disease has claimed> 3.3 million lives globally. As with many other diseases, inflammation is a key feature of COVID-19. When inflammation is overwhelming, it may lead to unfavorable outcomes or even death. Scientists all over the world are working tirelessly in search of therapeutic strategies to suppress or modulate inflammation in COVID-19. This review gives an overview of the role of inflammation in COVID-19. It also critically examines the various treatment approaches that target the immune system and inflammation in COVID-19, as well as highlights the key findings in the numerous studies conducted thus far.
引用总数
学术搜索中的文章
RSY Wong - International journal of clinical and experimental …, 2021